Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics
Open Access
- 17 October 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 29 (4), 673-680
- https://doi.org/10.1093/carcin/bgm228
Abstract
DNA mismatch repair (MMR) deficiency results in a strong mutator phenotype and high-frequency microsatellite instability (MSI-H), which are the hallmarks of tumors arising within Lynch syndrome. MSI-H is characterized by length alterations within simple repeated sequences, microsatellites. Lynch syndrome is primarily due to germline mutations in one of the DNA MMR genes; mainly hMLH1 or hMSH2 and less frequently hMSH6 and rarely hPMS2 . Germline hemiallelic methylation of MLH1 , termed epimutation, has been reported to be a new cause of Lynch syndrome. MSI-H is also observed in ∼15% of colorectal, gastric and endometrial cancers and in lower frequencies in a minority of other tumors, where it is associated with the hypermethylation of the promoter region of hMLH1 . MSI-H underlies a distinctive tumorigenic pathway because cancers with MSI-H exhibit many differences in genotype and phenotype relative to cancers without MSI-H, irrespective of their hereditary or sporadic origins. Genetic, epigenetic and transcriptomic differences exist between cancers with and those without the MSI-H. The BRAF V600E mutation is associated with sporadic MSI-H colorectal cancers (CRCs) harboring hMLH1 methylation but not Lynch syndrome-related CRCs. The differences in genotype and phenotype between cancers with and those without MSI-H are likely to be causally linked to their differences in biological and clinical features. Therefore, the diagnosis of MSI-H in cancers is thus considered to be of increasing relevance, because MSI-H is a useful screening marker for identifying patients with Lynch syndrome, a better prognostic factor and could affect the efficacy of chemotherapy. This review addresses recent advances in the field of microsatellite instability research.Keywords
This publication has 107 references indexed in Scilit:
- mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancerMolecular Cancer, 2007
- Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic studyGut, 2007
- Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)Journal of Medical Genetics, 2007
- Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cellsOncogene, 2006
- High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instabilityOncogene, 2006
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- CpG island methylator phenotype in cancerNature Reviews Cancer, 2004
- Manipulation of nonsense mediated decay identifies gene mutations in colon cancer Cells with microsatellite instabilityOncogene, 2004
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002
- A strategy for disease gene identification through nonsense-mediated mRNA decay inhibitionNature Biotechnology, 2001